Related references
Note: Only part of the references are listed.Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy
Kjell E. Oberg et al.
GASTROENTEROLOGY (2010)
Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability
Justyna Leja et al.
PLOS ONE (2010)
Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas
Justyna Leja et al.
MODERN PATHOLOGY (2009)
Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas
L. Fischer et al.
BRITISH JOURNAL OF SURGERY (2008)
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Ulrich-Frank Pape et al.
CANCER (2008)
Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution
Sara Ekeblad et al.
CLINICAL CANCER RESEARCH (2008)
Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis
Eva-Maria Duerr et al.
ENDOCRINE-RELATED CANCER (2008)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
TNM staging of midgut and hindgut (neuro) endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2007)
TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2006)
Staging of carcinoid tumours with 18F-DOPA PET:: a prospective, diagnostic accuracy study
Klaas P. Koopmans et al.
LANCET ONCOLOGY (2006)
Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
S Koukouraki et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and computed tomography
H Orlefors et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Current status of gastrointestinal carcinoids
IM Modlin et al.
GASTROENTEROLOGY (2005)
Hypothalamic hormones a.k.a. hypothalamic releasing factors
R Guillemin
JOURNAL OF ENDOCRINOLOGY (2005)
High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours
SV Welin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
A comparison between three commercial kits for chromogranin A measurements
M Stridsberg et al.
JOURNAL OF ENDOCRINOLOGY (2003)
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
JC Reubi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Tumor markers in neuroendocrine tumors
B Eriksson et al.
DIGESTION (2000)